←
Maze Therapeutics185 posts
Maze Therapeutics avatar

Maze Therapeutics

@MazeInBiotech

Impact Obsessed. Converting the power of modern human genetics into precision medicines for patients.

◷ Joined August 2021▧ 159 Photos and videos
Maze Therapeutics avatar
Maze Therapeutics@MazeInBiotech·Jun 9

Today Maze recognizes #FSGS Awareness Day for everyone living with this rare #kidneydisease and those who love and support them. Raising awareness may seem small, but it helps bring understanding, research, hope and reminds others they’re not fighting alone.

Post attachment
Maze Therapeutics avatar
Maze Therapeutics@MazeInBiotech·May 21

Living with PKU means your entire day’s protein budget is smaller than a single egg. 60,000 patients worldwide navigate this every day for life. This #PKUAwarenessMonth, Maze Therapeutics is proud to stand with the PKU community. Because patients deserve more than workarounds. 💜

Post attachmentPost attachmentPost attachmentPost attachment
Maze Therapeutics avatar
Maze Therapeutics@MazeInBiotech·Mar 25

We are pleased to announce positive topline data from the Phase 2 HORIZON trial of MZE829, an oral, small molecule, dual-mechanism APOL1 inhibitor, in patients with broad APOL1-mediated kidney disease (AMKD). Read the full announcement below and tune into our conference call at 8 am ET. ir.mazetx.com/news-releases/…

Post attachment
Maze Therapeutics avatar
Maze Therapeutics@MazeInBiotech·Mar 6

This #InternationalWomensDay, we’re celebrating the women of Maze whose ideas, leadership and dedication help move our science and mission forward every day. We’re proud to foster a workplace where women are supported, empowered and able to thrive. Because when women rise, we all go further together.

Post attachment
Maze Therapeutics avatar
Maze Therapeutics@MazeInBiotech·Feb 25

Our CEO Jason Coloma, Ph.D., will participate in a fireside chat at the 46th Annual TD Cowen Health Care Conference on Wednesday, March 4th at 10:30 a.m. ET in Boston. A live webcast of the event will be available in the Investors section of our website and archived for 60 days following the presentation. More info here: ir.mazetx.com/news-releases/…

Maze Therapeutics avatar
Maze Therapeutics@MazeInBiotech·Feb 12

In recognition of #BlackHistoryMonth, we welcomed Maze patient advisory committee member and #APOL1 #kidneydisease warrior Sharron Rouse for a powerful discussion on how APOL1 advocacy groups can better support patients, highlighting the importance of education, community, and patient voices. Hope begins with awareness and strong advocacy can transform the patient journey by empowering individuals, strengthening communities, and paving the way for meaningful change. Learn more about Sharron's patient advocacy group @kkidneys here: kindnessforkidneys.org/

Post attachmentPost attachmentPost attachment
Maze Therapeutics avatar
Maze Therapeutics@MazeInBiotech·Jan 29

One year ago, Maze took a major step forward with our debut as a public company. This week, we celebrated that milestone and our subsequent success, ringing the @NasdaqExchange opening bell in honor of our one-year #IPOanniversary. We’re proud of what we’ve accomplished together and energized by what’s ahead as we continue to execute in dedication to transforming the lives of patients living with kidney and metabolic diseases. $MAZE

0:21